Literature DB >> 15995796

Characterization of tremor in phenylketonuric patients.

Belén Pérez-Dueñas1, Josep Valls-Solé, Emilio Fernández-Alvarez, Jaon Conill, Maria Antonio Vilaseca, Rafael Artuch, Jaume Campistol.   

Abstract

Tremor of unknown origin is detected in 10-30% of early-treated and in more than 30% late-treated phenylketonuric patients. With the aim of characterizing tremor in phenylketonuria, we carried out a systematic study in 54 patients aged 6 to 37 years. Tremor examination was done by applying the WHIGET Tremor Rating Scale and by accelerometer recording (BYOPAC System MP100WSW). Age at diet onset, IQ test results, concomitant plasma phenylalanine levels and index of dietary control were also studied. Tremor was not observed at rest in any case, but was apparent in 22 patients (40.7%) when carrying out a kinetic task. In 15 patients tremor was also evident during maintenance of a postural task at a frequency ranging between 7.5 and 12.7 Hz. Frequency of tremor was not significantly modified by loading the arms or by increasing muscle contraction. Patients with tremor had a later age at onset of phenylalanine restricted diet (p < 0.001). Other treatment-related variables did not differ between patients with and without tremor. Our results of the neurophysiological examination suggest that tremor in phenylketonuric patients is dependent on a dysfunction of central nervous system networks and may be an index of cerebral damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15995796     DOI: 10.1007/s00415-005-0860-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  25 in total

1.  Measurement of neurotransmitter metabolites in the cerebrospinal fluid of phenylketonuric patients under dietary treatment.

Authors:  A B Burlina; L Bonafé; V Ferrari; A Suppiej; F Zacchello; A P Burlina
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 2.  Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor.

Authors:  P Brown; P D Thompson
Journal:  Mov Disord       Date:  2001-07       Impact factor: 10.338

3.  Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.

Authors:  Rosa Gassió; Rafael Artuch; Maria Antonia Vilaseca; Eugenia Fusté; Cristina Boix; Anna Sans; Jaume Campistol
Journal:  Dev Med Child Neurol       Date:  2005-07       Impact factor: 5.449

4.  Neurological abnormalities in phenylketonuria.

Authors:  H E Pedersen; E Birket-Smith
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

5.  Evidence for central nervous system glial cell plasticity in phenylketonuria.

Authors:  C A Dyer; A Kendler; T Philibotte; P Gardiner; J Cruz; H L Levy
Journal:  J Neuropathol Exp Neurol       Date:  1996-07       Impact factor: 3.685

Review 6.  Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities.

Authors:  D P Brenton; J Pietz
Journal:  Eur J Pediatr       Date:  2000-10       Impact factor: 3.183

7.  Cortical tremor. A common manifestation of cortical myoclonus.

Authors:  C Toro; A Pascual-Leone; G Deuschl; E Tate; M R Pranzatelli; M Hallett
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

8.  Neurological outcome in adult patients with early-treated phenylketonuria.

Authors:  J Pietz; R Dunckelmann; A Rupp; D Rating; H M Meinck; H Schmidt; H J Bremer
Journal:  Eur J Pediatr       Date:  1998-10       Impact factor: 3.183

Review 9.  Neurological aspects of adult phenylketonuria.

Authors:  J Pietz
Journal:  Curr Opin Neurol       Date:  1998-12       Impact factor: 5.710

10.  Tremor analysis in two normal cohorts.

Authors:  J Raethjen; M Lauk; B Köster; U Fietzek; L Friege; J Timmer; C H Lücking; G Deuschl
Journal:  Clin Neurophysiol       Date:  2004-09       Impact factor: 3.708

View more
  2 in total

Review 1.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 2.  Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features.

Authors:  Nattakarn Limphaibool; Piotr Iwanowski; Marte Johanne Veilemand Holstad; Katarzyna Perkowska
Journal:  Front Neurol       Date:  2018-10-12       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.